BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26841725)

  • 1. Regulating NKX3.1 stability and function: Post-translational modifications and structural determinants.
    Padmanabhan A; Rao V; De Marzo AM; Bieberich CJ
    Prostate; 2016 May; 76(6):523-33. PubMed ID: 26841725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilization of the prostate-specific tumor suppressor NKX3.1 by the oncogenic protein kinase Pim-1 in prostate cancer cells.
    Padmanabhan A; Gosc EB; Bieberich CJ
    J Cell Biochem; 2013 May; 114(5):1050-7. PubMed ID: 23129228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proline-mediated proteasomal degradation of the prostate-specific tumor suppressor NKX3.1.
    Rao V; Guan B; Mutton LN; Bieberich CJ
    J Biol Chem; 2012 Oct; 287(43):36331-40. PubMed ID: 22910912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 overexpression represses androgen-mediated induction of NKX3.1 in a prostate cancer cell line.
    Jiang A; Yu C; Zhang P; Chen W; Liu W; Hu X; Zhang J
    Exp Mol Med; 2006 Dec; 38(6):625-33. PubMed ID: 17202838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Tumor Suppressor NKX3.1 Is Targeted for Degradation by DYRK1B Kinase.
    Song LN; Silva J; Koller A; Rosenthal A; Chen EI; Gelmann EP
    Mol Cancer Res; 2015 May; 13(5):913-22. PubMed ID: 25777618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of prostate tumorigenesis: roles for transcription factors Nkx3.1 and Egr1.
    Abdulkadir SA
    Ann N Y Acad Sci; 2005 Nov; 1059():33-40. PubMed ID: 16382041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen regulation of the prostatic tumour suppressor NKX3.1 is mediated by its 3' untranslated region.
    Thomas MA; Preece DM; Bentel JM
    Biochem J; 2010 Jan; 425(3):575-83. PubMed ID: 19886863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional regulation of the homeobox gene NKX3.1 by all-trans retinoic acid in prostate cancer cells.
    Thomas MA; Hodgson MC; Loermans SD; Hooper J; Endersby R; Bentel JM
    J Cell Biochem; 2006 Dec; 99(5):1409-19. PubMed ID: 16817226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analysis of NKX3.1 in LNCaP prostate cancer cells by RNA interference.
    Possner M; Heuser M; Kaulfuss S; Scharf JG; Schulz W; Hermann-Ringert R; Thelen P
    Int J Oncol; 2008 Apr; 32(4):877-84. PubMed ID: 18360715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of PTEN Accelerates NKX3.1 Degradation to Promote Prostate Cancer Progression.
    Bowen C; Ostrowski MC; Leone G; Gelmann EP
    Cancer Res; 2019 Aug; 79(16):4124-4134. PubMed ID: 31213464
    [No Abstract]   [Full Text] [Related]  

  • 11. Germ-line mutation of NKX3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and function.
    Zheng SL; Ju JH; Chang BL; Ortner E; Sun J; Isaacs SD; Sun J; Wiley KE; Liu W; Zemedkun M; Walsh PC; Ferretti J; Gruschus J; Isaacs WB; Gelmann EP; Xu J
    Cancer Res; 2006 Jan; 66(1):69-77. PubMed ID: 16397218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression profile of an androgen regulated prostate specific homeobox gene NKX3.1 in primary prostate cancer.
    Xu LL; Srikantan V; Sesterhenn IA; Augustus M; Dean R; Moul JW; Carter KC; Srivastava S
    J Urol; 2000 Mar; 163(3):972-9. PubMed ID: 10688034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional activation of ATM by the prostate cancer suppressor NKX3.1.
    Bowen C; Ju JH; Lee JH; Paull TT; Gelmann EP
    Cell Rep; 2013 Aug; 4(3):516-29. PubMed ID: 23890999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory cytokines induce phosphorylation and ubiquitination of prostate suppressor protein NKX3.1.
    Markowski MC; Bowen C; Gelmann EP
    Cancer Res; 2008 Sep; 68(17):6896-901. PubMed ID: 18757402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion.
    Bethel CR; Faith D; Li X; Guan B; Hicks JL; Lan F; Jenkins RB; Bieberich CJ; De Marzo AM
    Cancer Res; 2006 Nov; 66(22):10683-90. PubMed ID: 17108105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer.
    Asatiani E; Huang WX; Wang A; Rodriguez Ortner E; Cavalli LR; Haddad BR; Gelmann EP
    Cancer Res; 2005 Feb; 65(4):1164-73. PubMed ID: 15734999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
    Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
    Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression studies and mutational analysis of the androgen regulated homeobox gene NKX3.1 in benign and malignant prostate epithelium.
    Ornstein DK; Cinquanta M; Weiler S; Duray PH; Emmert-Buck MR; Vocke CD; Linehan WM; Ferretti JA
    J Urol; 2001 Apr; 165(4):1329-34. PubMed ID: 11257711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitination by TOPORS regulates the prostate tumor suppressor NKX3.1.
    Guan B; Pungaliya P; Li X; Uquillas C; Mutton LN; Rubin EH; Bieberich CJ
    J Biol Chem; 2008 Feb; 283(8):4834-40. PubMed ID: 18077445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An NKX3.1 binding site polymorphism in the l-plastin promoter leads to differential gene expression in human prostate cancer.
    Chen C; Cai Q; He W; Li Z; Zhou F; Liu Z; Zhong G; Chen X; Zhao Y; Dong W; Huang J; Zheng J; Lin T
    Int J Cancer; 2016 Jan; 138(1):74-86. PubMed ID: 26148677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.